Results from a large post-marketing safety surveillance study in the Republic of Korea with a quadrivalent meningococcal CRM-conjugate vaccine in individuals aged 2 months-55 years.
Hum Vaccin Immunother
; 16(6): 1260-1267, 2020 06 02.
Article
in En
| MEDLINE
| ID: mdl-31634044
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Meningococcal Vaccines
/
Meningococcal Infections
/
Neisseria meningitidis
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Screening_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Hum Vaccin Immunother
Year:
2020
Type:
Article